Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health Studies

British Journal of Nutrition

Volumn 108, Issue 3, 2012, Pages 449-458

  Dorjgochoo, Tsogzolmaa ^a   Shu, Xiao Ou ^a   Xiang, Yong Bing ^b   Yang, Gong ^a   Cai, Qiuyin ^a   Li, Honglan ^b   Ji, Bu Tian ^c   Cai, Hui ^a   Gao, Yu Tang ^b   Zheng, Wei ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

25 Hydroxyvitamin D; Blood pressure parameters; China; Hypertension; Sex differences

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHINA; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEN'S HEALTH; NUTRITIONAL ASSESSMENT; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WOMEN'S HEALTH;

ADULT; AGED; BLOOD PRESSURE; CHINA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; SEX FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84865271599     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511005745     Document Type: Article

References (47)

1. Kinuta K, Tanaka H, Moriwake T, et al. (2000) Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 141, 1317-1324. (Pubitemid 32269098)
2. Li YC, Qiao G, Uskokovic M, et al. (2004) Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90, 387-392. (Pubitemid 38844316)
3. Holick MF (2005) Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J 98, 1024-1027. (Pubitemid 41572206)
4. Martini LA & Wood RJ (2008) Vitamin D and blood pressure connection: update on epidemiologic, clinical, and mechanistic evidence. Nutr Rev 66, 291-297. (Pubitemid 351623973)
5. O'Donnell S, Cranney A, Horsley T, et al. (2008) Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review. Am J Clin Nutr 88, 1528-1534.
6. Holden JM & Lemar LE (2008) Assessing vitamin D contents in foods and supplements: challenges and needs. Am J Clin Nutr 88, 551S-553S.
7. Holick MF (2009) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19, 73-78.
8. Muray S, Parisi E, Cardus A, et al. (2003) Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects. J Hypertens 21, 2069-2075. (Pubitemid 38296868)
9. Forman JP, Giovannucci E, Holmes MD, et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49, 1063-1069. (Pubitemid 351664326)
10. Scragg R, Sowers M & Bell C (2007) Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20, 713-719. (Pubitemid 46936167)
11. Scragg RK, Camargo CA Jr & Simpson RU (2010) Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). Am J Cardiol 105, 122-128.
12. Pittas AG, Chung M, Trikalinos T, et al. (2010) Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 152, 307-314.
13. Snijder MB, Lips P, Seidell JC, et al. (2007) Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 261, 558-565. (Pubitemid 46835978)
14. Nagpal J, Pande JN & Bhartia A (2009) A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26, 19-27.
15. Scragg R, Khaw KT & Murphy S (1995) Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 49, 640-646.
16. Argiles A, Lorho R, Servel MF, et al. (2002) Blood pressure is correlated with vitamin D(3) serum levels in dialysis patients. Blood Purif 20, 370-375. (Pubitemid 34920519)
17. Dorjgochoo T, Shu XO, Zhang X, et al. (2009) Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinesewomen: a population-based prospective study. J Hypertens 27, 468-475.
18. Fang XH, Longstreth WT Jr, Li SC, et al. (2001) Longitudinal study of blood pressure and stroke in over 37,000 People in China. Cerebrovasc Dis 11, 225-229. (Pubitemid 32304636)
19. Jurj AL, Wen W, Xiang YB, et al. (2007) Reproducibility and validity of the Shanghai Men's Health Study physical activity questionnaire. Am J Epidemiol 165, 1124-1133. (Pubitemid 47233711)
20. Zheng W, Chow WH, Yang G, et al. (2005) The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 162, 1123-1131. (Pubitemid 41746625)
21. Gallicchio L, Helzlsouer KJ, Chow WH, et al. (2010) Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172, 10-20.
22. Chobanian AV, Bakris GL, Black HR, et al. (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206-1252. (Pubitemid 37553153)
23. Shu XO, Yang G, Jin F, et al. (2004) Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study. Eur J Clin Nutr 58, 17-23. (Pubitemid 38159308)
24. Yang G, Wang G & Pan X (2002) China Food Composition. Beijing: Peking University Medical Press.
25. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135, 317-322. (Pubitemid 40194499)
26. World Health Organization and Food and Agricultural Organization of the United Nations (2004) Vitamin and Mineral Requirements in Human Nutrition. Geneva: WHO.
27. Lu L, Yu Z, Pan A, et al. (2009) Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middleaged and elderly Chinese individuals. Diabetes Care 32, 1278-1283.
28. Tomaschitz A, Pilz S, Ritz E, et al. (2010) Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 411, 1354-1360.
29. Wang TJ, Pencina MJ, Booth SL, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511.
30. Young EW, McCarron DA & Morris CD (1990) Calcium regulating hormones in essential hypertension. Importance of gender. Am J Hypertens 3, 161S-166S.
31. Gunnarsson O, Indridason OS, Franzson L, et al. (2009) Factors associated with elevated or blunted PTH response in vitamin D insufficient adults. J Intern Med 265, 488-495.
32. Schmitz KJ, Skinner HG, Bautista LE, et al. (2009) Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans. Am J Hypertens 22, 867-870.
33. Gannage-Yared MH, Chedid R, Khalife S, et al. (2009) Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 160, 965-971.
34. Gallagher JC & Sai AJ (2010) Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab 95, 2630-2633.
35. Muray S, Marco MP, Craver L, et al. (2006) Influence of mineral metabolism parameters on pulse pressure in healthy subjects. Clin Nephrol 66, 411-417. (Pubitemid 44896149)
36. Reichel H, Liebethal R, Hense HW, et al. (1992) Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig 70, 748-751.
37. Chan R, Chan D, Woo J, et al. (2011) Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. J Hum Hypertens (epublication ahead of print version 20 January 2011).
38. Lind L, Wengle B, Wide L, et al. (1988) Hypertension in primary hyperparathyroidism-reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. Am J Hypertens 1, 397-402.
39. Lind L, Wengle B, Wide L, et al. (1989) Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens 2, 20-25. (Pubitemid 19031898)
40. Pfeifer M, Begerow B, Minne HW, et al. (2001) Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86, 1633-1637. (Pubitemid 32377290)
41. Martins D, Wolf M, Pan D, et al. (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167, 1159-1165. (Pubitemid 46919818)
42. Jorde R, Figenschau Y, Emaus N, et al. (2010) Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 55, 792-798.
43. Rueda S, Fernandez-Fernandez C, Romero F, et al. (2008) Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 18, 151-154.
44. Parker J, Hashmi O, Dutton D, et al. (2009) Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65, 225-236.
45. Krause R, Buhring M, Hopfenmuller W, et al. (1998) Ultraviolet B and blood pressure. Lancet 352, 709-710. (Pubitemid 28398716)
46. Weber KT, Rosenberg EW & Sayre RM (2004) Suberythemal ultraviolet exposure and reduction in blood pressure. Am J Med 117, 281-282. (Pubitemid 39092725)
47. Oplander C, Volkmar CM, Paunel-Gorgulu A, et al. (2009) Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ Res 105, 1031-1040.